Quick answer
What does regenerative medicine study?
In the reviews cited here, regenerative medicine refers to research on repairing or restoring injured tissues and organs, often through cells, the vesicles they release, or tissue-derived materials12. Much of the evidence described comes from laboratory and animal studies, while human clinical trials of MSC-derived vesicles remain few1.
How does regenerative medicine research work?
Research in this field often starts by studying how cells behave in laboratory cultures and in animal models before any human testing is considered31. A 2022 review explains that mesenchymal stem cells can move toward areas of tissue injury, contribute to immune modulation and release anti-inflammatory cytokines3. The same review reports that laboratory and animal investigations have shown anti-inflammatory, anti-aging, reconstruction and wound-healing potentials for these cells3. Other lines of research focus less on the cells themselves and more on the messages they send1. The 2020 review notes that this cell-free possibility raises separate questions about how vesicles are produced, isolated and administered1.
| Approach | What the cited review describes | Evidence stage described | Source |
|---|---|---|---|
| Mesenchymal stem cells | Cells that move to injury and influence immune and repair processes | Laboratory and animal work; clinical application reviewed | 3 |
| MSC-derived extracellular vesicles | Vesicles released by MSCs and studied for restoring injured tissues | Pre-clinical laboratory and animal evidence; few human trials | 1 |
| Exosomes | Extracellular vesicles carrying molecular cargo between cells | Emerging; healing properties and applications described as potential | 4 |
| Decellularized extracellular matrix | Tissue-derived material retaining structural proteins and small molecules | Development; fabrication progress reviewed and described as promising | 2 |
These approaches are not interchangeable: cell-based work uses living cells, while vesicle and matrix work uses products derived from cells or tissues312. The reviews discuss each with its own set of laboratory methods and open questions412.
- Cell-based research: MSCs are studied for immunomodulation and tissue regeneration3.
- Vesicle-based research: MSC-derived extracellular vesicles are studied as potential mediators of repair1.
- Exosome research: exosomes are studied for the cargo they carry and their role in intercellular communication4.
- Biomaterial research: decellularized extracellular matrix is studied as a scaffold for tissue repair2.
What are mesenchymal stem cells?
Mesenchymal stem cells are multipotent cells that can move toward injured tissue and take part in immune modulation, according to a 2022 review3. The review describes them as having immunomodulatory and immunosuppressive activities and notes that laboratory and animal studies have examined their anti-inflammatory and repair-related effects3. It also states that progress in MSC biology has helped support specific guidelines and quality-control approaches for clinical application3.
Where do MSCs used in research come from?
A 2020 review reports that the effects attributed to MSC-derived vesicles were apparently found regardless of the anatomical or body-fluid origin of the cells, with bone marrow, adipose tissue, umbilical cord and urine among the origins listed1. That evidence is described as predominantly pre-clinical, coming from laboratory and animal studies1. Early indications also suggest that the effects of these vesicles could be enhanced by changing how the donor cells are cultured, such as in low-oxygen versus standard conditions or in three-dimensional versus flat formats1. Readers new to the vocabulary can begin with what stem cell treatment involves, while the 2020 review concentrates on the vesicles MSCs release1.
What are extracellular vesicles and exosomes?
Extracellular vesicles are particles released by cells; exosomes are one type, formed inside multivesicular bodies and then released into the space around the cell4. A 2021 review explains that the cargo of exosomes is varied, and among the components it lists are lipids, enzymes, receptors on the cell surface, signaling molecules and genetic material, which lets them take part in communication between cells, differentiation, proliferation, blood vessel formation, stress response and immune signaling4. The review describes exosomes as candidates for tissue engineering and regenerative medicine because of properties such as biocompatibility and stability4. Separately, the 2020 review focused on vesicles released by MSCs suggests that the beneficial effects of MSCs may be carried by these released vesicles rather than requiring administration of the cells themselves1.
What is being studied in regenerative medicine, and what stays open?
The reviews describe investigation across a wide range of tissues and conditions, from neurological and heart disease to wound healing and engineered materials342. The 2022 MSC review discusses therapeutic responses in neural, liver, kidney, bone and heart diseases, as well as wound healing3. The exosome review discusses emerging healing properties in brain injuries, cardiovascular disease and COVID-19, among others4. The decellularized matrix review reports that particle-based materials derived from it have been built with the aim of engineering more than 15 different tissue types or organs2.
| Review focus | Areas discussed | What the review reports | Source |
|---|---|---|---|
| Mesenchymal stem cells | Neural, liver, kidney, bone and heart diseases; wound healing | Therapeutic responses reviewed | 3 |
| Exosomes | Brain injuries, cardiovascular disease and COVID-19, among others | Emerging healing properties discussed | 4 |
| MSC-derived extracellular vesicles | Injured or diseased tissues and organs | Pre-clinical evidence suggesting possible restorative effects | 1 |
| Decellularized extracellular matrix | More than 15 tissue types or organs | Biomaterial scaffolds developed | 2 |
The 2020 review on MSC-derived vesicles states that further research is warranted to establish how best to use this approach1, and the matrix review discusses the elements needed to move these biomaterials toward specialized tissue repair2.
- For MSC-derived vesicles, reviewers ask whether the mixed population of vesicles is beneficial or only certain sub-populations are1.
- They also ask how best to culture and scale up MSC-derived vesicle production and isolation for clinical use1.
- They ask in what format MSC-derived vesicles should be administered1.
- For decellularized matrix, the 2022 review highlights fabrication methods, challenges and progress for each tissue type2.
Frequently asked questions
Is regenerative medicine the same as stem cell therapy?
Not exactly. Stem cell research is one part of regenerative medicine, which also includes cell-free approaches such as extracellular vesicles and biomaterial scaffolds; the reviews describe these as separate research lines with different evidence12.
Are regenerative medicine treatments proven?
No. The reviews describe substantial pre-clinical evidence, but a 2020 review notes that few human clinical trials of MSC-derived extracellular vesicles have been conducted and that key questions remain1.
What are exosomes in regenerative medicine?
Exosomes are extracellular vesicles released by cells that carry a varied molecular cargo; researchers are exploring their roles in intercellular communication and tissue engineering4.
What is decellularized extracellular matrix?
Decellularized extracellular matrix is tissue-derived material processed to retain structural proteins, glycosaminoglycans and small molecules, and it is being developed as a biomaterial for tissue repair2.



